Matches in Nanopublications for { ?s ?p "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 25 of
25
with 100 items per page.
- NP667536.RADSp6zUuxytEEWsrg8EYOas7beEJ9ytTuZAYULAdk_U8130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667536.RADSp6zUuxytEEWsrg8EYOas7beEJ9ytTuZAYULAdk_U8130_provenance.
- NP768470.RAkoz2erOA_dPJkb3kQEP4p7CHpLrJwV8-UdfHvW0tVbU130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768470.RAkoz2erOA_dPJkb3kQEP4p7CHpLrJwV8-UdfHvW0tVbU130_provenance.
- NP240731.RAh5LQ2gHCnuLcPlPg_ait1rZlXZhhI2cWz2spYhOWxEE130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240731.RAh5LQ2gHCnuLcPlPg_ait1rZlXZhhI2cWz2spYhOWxEE130_provenance.
- NP923695.RAXtNyr6hJFCxSA8u2dKrw-1QhG4_snzApxgrxd6qhGZo130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923695.RAXtNyr6hJFCxSA8u2dKrw-1QhG4_snzApxgrxd6qhGZo130_provenance.
- NP473395.RA361KtbSgeM-b76qidvQIs3tguHe5WunH5rRwMKprEME130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP473395.RA361KtbSgeM-b76qidvQIs3tguHe5WunH5rRwMKprEME130_provenance.
- NP437150.RAjycn9u6bGAv77vjU1iTCStlDnKREskQJrTbnBf3eHsA130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437150.RAjycn9u6bGAv77vjU1iTCStlDnKREskQJrTbnBf3eHsA130_provenance.
- NP575154.RAo1IlJkIZ2r4b8GQqwXXKKEEOlwmMKMIULLAFAJGmrZ0130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575154.RAo1IlJkIZ2r4b8GQqwXXKKEEOlwmMKMIULLAFAJGmrZ0130_provenance.
- NP752399.RAsDZxzAn90swMnLechKH5puu1Bwf0qTaB669PX80aiMs130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752399.RAsDZxzAn90swMnLechKH5puu1Bwf0qTaB669PX80aiMs130_provenance.
- NP506943.RAVl-2kfYkCnuBOfUpkVOdFphXTcxhP7YTbMRQJ7xISOo130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP506943.RAVl-2kfYkCnuBOfUpkVOdFphXTcxhP7YTbMRQJ7xISOo130_provenance.
- NP319496.RA8MN8GlkfUZSAm6-YwtGcC0Ek_-5nS_TD-skXkNOPVHo130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP319496.RA8MN8GlkfUZSAm6-YwtGcC0Ek_-5nS_TD-skXkNOPVHo130_provenance.
- NP442998.RA3FxnFC5oAg-Pg2UidM73tZFvnhjMMoXI7MxhmUr9LTM130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442998.RA3FxnFC5oAg-Pg2UidM73tZFvnhjMMoXI7MxhmUr9LTM130_provenance.
- NP625356.RAQT_6kJy0MFggc_KICrS9bN66lJ3fKtkiyFb1mi8GfHo130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625356.RAQT_6kJy0MFggc_KICrS9bN66lJ3fKtkiyFb1mi8GfHo130_provenance.
- NP518929.RA2-OFQLTxZXxidr0a5OlZxlPkpy_hjfg6RF5l7k5UEm8130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518929.RA2-OFQLTxZXxidr0a5OlZxlPkpy_hjfg6RF5l7k5UEm8130_provenance.
- assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP904911.RA0EHbojJbPBOi0uuDmO-n7ZfVD7du9DvCSH0xX65_xNE130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904911.RA0EHbojJbPBOi0uuDmO-n7ZfVD7du9DvCSH0xX65_xNE130_provenance.
- NP709132.RA4vW2JJNlkgOC1ufjw8esBlnOfDp3SczJwwvlcSVwefI130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709132.RA4vW2JJNlkgOC1ufjw8esBlnOfDp3SczJwwvlcSVwefI130_provenance.
- assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP774165.RAIrKT31WxCmHGlD2XGEP0LTDPprGON_nPTdBcUr_J34k130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP774165.RAIrKT31WxCmHGlD2XGEP0LTDPprGON_nPTdBcUr_J34k130_provenance.
- NP795755.RAGDqz4DFPs8O6MipR8z2LnN1i8QfmUGMEoPM5Yt1mtZQ130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795755.RAGDqz4DFPs8O6MipR8z2LnN1i8QfmUGMEoPM5Yt1mtZQ130_provenance.
- NP1111377.RADBqMM6_AfquAxOqBqZKSxW0koOfkhpuU3wtMENqR1hA130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111377.RADBqMM6_AfquAxOqBqZKSxW0koOfkhpuU3wtMENqR1hA130_provenance.
- NP1111378.RAAsAP7Nj52Xdp9fn9cWD729phk0RmZ5Gft3cqQXQ9HKg130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111378.RAAsAP7Nj52Xdp9fn9cWD729phk0RmZ5Gft3cqQXQ9HKg130_provenance.
- NP845346.RAtXaJWnXk7RkAqE5fOgRkNxxzD1dXLMxwXPBcbtL4yvY130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP845346.RAtXaJWnXk7RkAqE5fOgRkNxxzD1dXLMxwXPBcbtL4yvY130_provenance.
- NP1111376.RAv-VqGLeN15U-hr6BVI6224AQoRyIsAIlJJbLUDD2Mow130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111376.RAv-VqGLeN15U-hr6BVI6224AQoRyIsAIlJJbLUDD2Mow130_provenance.
- NP303135.RAOzDmMC1AOuqLPv-X44IgTsLgSb3ne2Phl7f26FHo3fE130_assertion description "[T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303135.RAOzDmMC1AOuqLPv-X44IgTsLgSb3ne2Phl7f26FHo3fE130_provenance.